Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Porto, Gaetana  [Clear All Filters]
Journal Article
Canale FAntonio, Pitea M, Alati C, Porto G, Pratico G, Utano G, Germanò J, Imbalzano L, Ferreri A, Verduci C, et al. Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantation. Eur J Haematol. 2023.
Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.
Martino M, Gori M, Porto G, Pellicano M, Santoro L, Verduci C, Canale FAntonio, Loteta B, Moscato T, Alati C, et al. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation. Ann Hematol. 2023.
Martino M, Canale FAntonio, Porto G, Verduci C, Utano G, Policastro G, Germanò J, Alati C, Santoro L, Imbalzano L, et al. Integrating CAR-T cell therapy into the management of DLBCL: what we are learning. Expert Opin Biol Ther. 2023:1-9.
Canale FA, Martino M, Porto G, Verduci C, Console G, Irrera G, Loteta B, Naso V, Pugliese M, Moscato T, et al. The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic. Support Care Cancer. 2023;31(6):350.